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Antibiotic-loaded polymethylmethacrylate beads
for the treatment of extracavitary vascular surgical
site infections
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James R. Campbell II, MD, Ashley Parker, MD, Stephanie Thompson, PhD, and
Ali F. AbuRahma, MD, Charleston, WVa
Objective:This study assessed the efficacy of antibiotic-loaded polymethylmethacrylate (PMMA) beads in the treatment of
lower extremity vascular surgical site infections (VSSIs).
Methods: This was a retrospective review of all patients with a VSSI of a lower extremity bypass treated with
antibiotic-loaded PMMA beads and culture-specific antibiotics during a 4.5-year period. Data collected included patient
demographics, comorbidities, site of initial graft infection, symptoms and signs at presentation, initial and additional
surgical debridement, wound culture results, type of antibiotic beads implanted, and graft treatment strategy, comprising
conduit preservation or in situ replacement, with associated soft tissue management by muscle flap or vacuum-assisted
closure. Primary outcome measures included death, recurrent infection, and limb salvage.
Results: Forty patients developed 42 extracavitary lower extremity VSSIs (bilateral groin infections in two). Patients were
treated according to our treatment algorithm with antibiotic-impregnated PMMA beads. Previous reconstructions
included nine aortofemoral bypasses (groin infection only), 20 infrainguinal bypasses, five extra-anatomic bypasses, five
femoral interpositions, two combined inflow–outflow bypass procedures, and one patch angioplasty with VSSI. Cultures
isolated 59 pathogens (39 gram-positive, 18 gram-negative, 2 Candida spp). Methicillin-resistant Staphylococcus aureus
was cultured from 10 VSSs (23.8%) overall and from 27.7% of those patients with attempted graft preservation or in situ
reconstructions. Two patients (4.8%) had no growth despite clinical signs of infection. Repeat VSS exploration and
culture results led to an average of 1.4 bead replacements before definitive treatment. Final treatment strategy included
graft preservation of patent bypasses in 28, partial graft excision with in situ replacement in eight, graft removal only with
residual graft remaining at implant site (ie, incorporated anastomotic conduit, 11.9%) in five, and extra-anatomic
reconstruction in one. Sartorius muscle flap was performed in 14 groin infections (37.8%). The 30-day mortality was 0%,
and limb loss was 7.1% (n  3). At the median follow-up of 17 months, the limb loss was 21.4% and the recurrent
infection rate was 19.4% (seven of 36) in those with attempted graft preservation or in situ replacement.
Conclusions: Antibiotic-loaded PMMA beads may serve as an adjunct in the management of VSSIs and may also expand
treatment options for graft preservation or in situ reconstruction, with expected recurrent infection rate approaching
20%. Further experience with this adjunct may help elucidate its role in the management of this complicated problem,
including the need for bead exchanges, until perigraft cultures are free of microbes. ( J Vasc Surg 2012;55:1706-11.)
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MVascular surgical site infection (VSSI) poses a signifi-
cant risk of morbidity and death for patients with this
undesired complication.1-4 Classic management of this
challenging problem includes complete removal of a pros-
thetic implant with extra-anatomic reconstruction.5 Other
management strategies have included selected in situ re-
placement or graft preservation. The later may be achieved
by local wound debridement, irrigation systems, and the
use of adjacent muscle rotational flap coverage.
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1706Graft preservation or in situ reconstructions have been pro-
osed by using implantable adjuncts to traditional irrigation, and
rainage of infected extracavitary sites has been described by a
roup from the University of South Florida (USF).6 This in-
luded the use of antibiotic-loaded beads to provide concen-
rated local delivery of antibiotics at the site of infection. The
otential advantage of this approach is to avoid possible complex
econstructive surgery in patients who are likely severely ill. The
SF experience reported no perioperative deaths and only an
1%recurrent infection rate,withnoearlyor late limb loss.These
urgeries can be complicated by additional wound healing prob-
ems and infections and often have inferior conduit patency
ompared with in-line arterial procedures.
The conservative approach of graft preservation may play a
ole when native vessels are not available, especially because
xtra-anatomic or impregnated prosthetic vascular grafts may
arry a significant risk of recurrence.7,8 In this report, we review
ur experience with antibiotic-impregnated beads for VSSIs.
ETHODS
Patient population. We retrospectively reviewed all
ases performed by our vascular section using polymethyl-
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Volume 55, Number 6 Stone et al 1707methacrylate (PMMA) beads that were identified by im-
plant record from July 2006 to June 2011, after obtaining
approval from our Institutional Review Board.We included
patients with a minimum of 30 days of follow-up. The
criteria for antibiotic bead implant included clinical signs of
an infected surgical site after vascular reconstruction. All
patients in this cohort had clinical signs of infection, with
cultures taken adjacent to the conduit with the anastomosis
exposed (ie, Szilagyi III infections). This was standard
practice by our group during this study period.
Exclusion criteria for graft preservation included pa-
tients with anastomotic aneurysms, active bleeding, or the
presence of bacteremia. Antibiotic beads were routinely
placed during this period for any patient taken to the
operating room for suspicion of infection after a previous
lower extremity revascularization procedure. In all patients
with both early and late infections, fluid or soft tissue
samples were taken for culture at the time of operative
surgical debridement.
Onset of clinical manifestations of graft infection was
3 months of the index procedure in 36 patients (early
graft infection) and 3 months in four patients (late graft
infection). Presenting symptoms and signs of graft infec-
tions included purulent drainage from a site of previous
surgical reconstruction, abscess, sinus tract, bleeding from
the anastomotic site or pseudoaneurysm, and bacteremia
(Table I). All patients were given broad-spectrum antibiot-
ics at the time of admission, typically including weight-
based dosing of vancomycin and dosing of piperacillin/
tazobactam according to the patient’s renal function. These
antibiotics were continued through the patient’s hospital
course, and the spectrum of antibiotic was narrowed once
final wound and graft cultures were obtained. After hospital
discharge, all patients received an intravenous or oral culture-
specific antibiotic for a minimum of 6 weeks.
Conduit/type of previous vascular reconstruction. The
types of conduit that had previously been implanted
included 31 polytetrafluoroethylene (PTFE) grafts, five
Dacron grafts, five autologous tissue grafts, and one
bovine pericardial patch. Previous graft reconstructions
included nine aortobifemoral, one axillobifemoral, and
four femorofemoral bypasses, 20 infrainguinal reconstruc-
tions (femoropopliteal/tibial bypass), five femoral interpo-
sitions, two combined inflow–outflow procedures, and one
common femoral artery patch angioplasty (Table II). Bilat-
Table I. Presentation of vascular site infections
Symptom
No.a
(N  42)
Abscess 16
Bacteremia 4
Erythema/drainage with positive culture 19
False aneurysm/bleeding 5
Sinus tract 2
aPatients could have more than one presenting symptom.eral groin infections occurred in one patient after aortobi- oemoral bypass and in another patient after bilateral com-
on femoral interpositions.
Operative technique. Surgical exploration of the in-
ected site included removal of all necrotic tissue and pulse
avage irrigation of the site with 3 liters of normal saline.
his was followed by irrigation with a mixture of hydrogen
eroxide, Betadine, and saline, with amounts totaling
500 mL. Antibiotic beads were made by the operating
oom staff using PMMA powder (40 grams) polymerized
ith methacrylate (20 mL) and vancomycin (2 grams),
obramycin (1 gram), or gentamycin (1 gram). The
ntibiotic-loaded PMMA cement was placed in 5-mm
olds and attached to an Ethibond suture (Ethicon,
omerville, NJ).
The hardened antibiotic beads were implanted within
he explored surgical site as a bead-string adjacent to the
nfected conduit. In most of the patients, the beads were
laced within the surgical site adjacent to the anastomosis,
ith overlying soft tissue coverage when possible. Nylon
utures were used to close the skin or a vacuum-assisted
ressing was placed if the defect was too large to close
rimarily.
Three surgeons performed the operative procedures.
lthough repeat operative washouts until perigraft fluid
nd tissue lacked bacterial isolates was encouraged, only
ne set of antibiotic beads was placed in most cases, which
as determined by the postoperative appearance of the
urgical site by the attending physician.
Depending on surgeon preference, the beads would be
emoved at the bedside or the patient would undergo
urther irrigation and debridement in the operating room.
oth of these treatment strategies were done 48 to 72
ours. This time of re-exploration was based on the USF
xperience with antibiotic beads. Cultures were routinely
btained if the patient returned to the operating room. At
he discretion of the surgeon, the beads were removed or
eplaced.
Sterile results from VSS cultures were not routinely
btained or required for the definitive procedure to be
erformed because our group used the clinical appearance
f the wound instead of culture evidence that the VSS was
ree of bacteria by standard culture techniques. The deci-
ion to perform a sartorius muscle flap was at the discretion
able II. Type of infected bypass in 42 vascular surgical
ites
econstruction
Prosthetic
(No.)
Vein
(No.)
Total
(No.)
ommon femoral interposition 5 0 5
ommon femoral patch (bovine) 0 1 1
emoral popliteal/tibial 15 5 20
emorofemoral bypass 4 0 4
ortofemoral 9 0 9
xillofemoral 1 0 1
ombined inflow–outflow 2 0 2
otal 42f the surgeon. Operative reports and a review with physi-
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June 20121708 Stone et alcians in our group were made to determine which patients
had intended graft preservation, in situ replacement, or
another procedure.
RESULTS
Early VSSI (3 months) occurred in 36 patients (90%)
and four (10%) presented with late VSSI. Of these, 87% had
undergone previous reconstructions at our institution, and
13% were referred from other facilities.
Wound cultures obtained at the time of VSS explora-
tion isolated 57 pathogens (Table III).Methicillin-resistant
Staphylococcus aureus (MRSA) was cultured from 10 of the
42 (23.8%) infected surgical sites. Nine patients and 10
surgical sites cultured MRSA at the initial washout. Vanco-
mycin beads were placed in nine of the 10 vascular site
infections during treatment, and gentamycin beads were
placed in one patient. Nine of the 10 MRSA VSS incisions
with infection were treated with vacuum-assisted dressings,
and eight had rotation of a sartorius muscle flap. An early
recurrent MRSA infection developed in four of the VSS
incisions, for which vancomycin beads were placed. Three
of the four recurrent MRSA infections were polymicrobial
infections, including gram-negative or anaerobes. Three of
the four VSS with recurrent infections had sartorius muscle
flaps, and vacuum-assisted dressings were used in all four
MRSA recurrent incision infections.
The final culture of the perigraft fluid at the time of
initial bead placement identified 39 gram-positive organ-
isms, 18 gram-negative, and no organisms in two patients.
More than one organism was cultured from 17 sites
(40.1%). The initial beads placed included vancomycin in
Table III. Type and number of bacterial and fungal
isolates recovered from 42 vascular surgical sites
Type No.
Gram-positive
Staphylococcus aureus
Methicillin-resistant 10
Methicillin-sensitive 5
S epidermidis 6
Enterococcus 7
Streptococcus spp 2
Methicillin-resistant S epidermidis 1
Vancomycin-resistant Enterococcus 1
Bacteroides spp 7
Total 39
Gram-negative
Escherichia coli 7
Pseudomonas 3
Haemophilus 1
Proteus 1
Citrobacter 1
Klebsiella 1
Enterobacter 2
Propionibacterium acnes 2
Total 18
Candida 2
No growth 239 patients (92.8%), gentamycin in 12 (28.6%), and tobra- pycin in one (2.4%); at times, more than one type of bead
as placed initially.
A total of 36 surgical sites in 34 patients were consid-
red for graft preservation or in situ replacement, in which
even recurrent or persistent infections occurred. Of the 28
ttempted graft preservations for VSSI, five (17.8%) were
reated for residual or recurrent infection, and two of eight
25%) of those that were treated with in situ replacement
equired further surgical revision.
Anastomotic bleeding of a cadaveric arterial segmental
eplacement of a polymicrobial groin infection of an aorto-
emoral limb, which ultimately underwent axillopopliteal
rosthetic bypass grafting that also failed, required ipsilat-
ral amputation. The second failure of in situ replacement
ncluded a polymicrobial infection that developed early
leeding from the anastomosis and subsequently required
n extra-anatomic bypass, which eventually thrombosed,
esulting in one of our late amputations.
A vacuum dressing was used during the postoperative
ound care in 27 surgical sites of 42 patients. A vacuum
ressing was used in the seven patients whose treatment
ad failed. Sartorius muscle flaps were performed in 14 of
7 patients (48.6%) with groin infections, of which five of
even failures had a sartorius muscle flap.
Antibiotic beads were replaced a mean of 1.4 times
range, 1-3). One set of antibiotic beads was used in 30 of
2 sites (71.4%), two sets of beads in nine sites (21.4%), and
hree sets of beads in three sites (7.1%). Four surgical sites
ad one antibiotic string of beads placed and three surgical
ites had more than one bead exchange, for a mean of 1.7
ead exchanges. This is in comparison with 1.4 bead ex-
hanges in the entire cohort.
Treatment sites included groins in 37 of 42 patients
88.1%) and other lower extremity surgical sites in five
11.9%), including thigh/popliteal incision.
Outcomes at 30 days included no deaths or allergic
eactions; however, limb loss occurred in three patients
7.1%). One patient had a polymicrobial groin infection of
n aortobifemoral graft. The patient underwent partial
raft excision and in situ cadaver arterial replacement/
uscle flap, but bleeding developed from the arterial anas-
omosis. The patient underwent femoral artery ligation and
xillopopliteal bypass, which failed and resulted in early
imb loss.
The second patient was bacteremic and underwent
omplete removal of an infected femoral to the above-knee
rosthetic bypass and placement of a femoral tibial saphe-
ous vein bypass. Despite a patent bypass, progressive
schemia associated with septic shock resulted in limb loss.
The third patient presented with infection by anasto-
otic disruption of the outflow limb of a femorofemoral
ypass with ipsilateral prosthetic femoral to the above-knee
opliteal graft, which had to be removed, with no option
or limb salvage.
The mean follow-up was 17 months; during this time,
n additional 6 of 39 patients (15.3%) had subsequent limb
oss. Graft occlusion also occurred in an additional two
atients but without limb loss. Recurrent or residual infec-
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Volume 55, Number 6 Stone et al 1709tion, defined as infection at the site of antibiotic bead
placement, developed in seven surgical sites (19.4%), rang-
ing from30 days to 2 years. Treatment with graft preser-
vation or in situ replacement failed in seven of 36 surgical
sites (19.4%), with an overall success rate of 80.6%. Six of
the seven recurrent infections were early and one was late,
presenting as a draining sinus and was treated with suppres-
sive oral antibiotics, without signs of abscess or sepsis at 2
years after identification of the sinus tract. No patient
developed an anastomotic aneurysm during the follow-up
period. Table IV describes recurrent infections that oc-
curred in the study cohort. Long-term survival was 90%,
with no deaths related to infection-related complications.
DISCUSSION
Diagnoses of vascular graft infections are difficult and
considered one of the most challenging scenarios to vascu-
lar surgeons. Mortality in patients with peripheral vascular
graft infection has been reported up to 17% and can occur
secondary to sepsis, myocardial infarction, and stroke.7,9,10
This group represents largely early Szilagyi III infections,
with few patients presenting3 months after their vascular
procedure. The cohort also represents a heterogeneous
group of previous vascular reconstructions, including aor-
tobifemoral, axillobifemoral, or bifemoral bypass. Patients
with infrainguinal reconstructions were also included and
some with combined inflow–outflow procedures. Despite
this heterogeneous group of previous vascular procedures,
the groin represented the most common site of infection,
occurring in 90% of cases.
Complete removal of an infected extracavitary implant
is the gold standard treatment against which all other
methods are compared.11 Graft preservation is appealing
because this management strategy requires no additional
vascular reconstruction. Calligaro et al5 reported a 20-year
experience with povidone-iodine soaked dressing changes
three times daily to promote granulation tissue coverage
over exposed grafts. They reported a low risk of recurrent
infection and acceptable amputation rates. Others have
used muscle flap coverage, with and without antibiotic-
impregnated beads, to salvage grafts.12,13 In situ graft
replacements can be optimal in selected cases, depending
on the extent of infection and bacterial characteristics.
Depending on the index procedure performed, significant
Table IV. Details of seven recurrent vascular surgical site
Index procedure Initial culture Manage
CFA interposition-PTFE MRSA GP/SM
CFA interposition-PTFE MRSA GP/SM
Infected limb ABF-Dacron MRSA GP
Limb of ax-bi-fem-PTFE Polymicrobial In situ v
Fem-tibial PTFE Escherichia coli GP
ABF-PTFE Polymicrobial 1 GP
ABF-Dacron MRSA, Bacteroides spp In situ c
ABF, Aortobifemoral; Ax-bi-fem, axillary-bifemoral; CFA, common femoral
PTFE, polytetrafluoroethylene; SMF, sartorius muscle flap; VAC, vacuum-amorbidity and risk of limb loss may occur. In cases of trevious aortofemoral bypass with isolated groin infections,
bturator bypass allows an extra-anatomic reconstruction
n an uninfected field. However, long-term durability in
atients with atherosclerotic disease approaches 70% at 1
ear, and infection in the new surgical site has been re-
orted.14
Delivering a concentrated topical dose of antibiotic is
he basis of antibiotic-bonded grafts, and this method has
een illustrated in many studies.15–19 Shue et al15 demon-
trated that antibiotic-bonded Dacron implants are highly
esistant to infection, with a similar description outlined by
orsello et al.16 One animal model study demonstrated
hat gelatin-sealed vascular grafts prebonded with antibiot-
cs were more resistant to S aureus.17 In other studies,
ifampicin-soaked grafts showed more resistance to
ethicillin-resistant S epidermidis.18,19 The feasibility of in
itu replacement with cryopreserved aortic allografts has
een demonstrated in animal models and was found to be
ore resistant to reinfection than synthetic grafts after in
itu replacement of an infected prosthetic graft.
Antibiotic beads provide focal local delivery of antibi-
tics to the site of infection and, therefore, may improve the
ate of graft salvage and minimize extra-anatomic recon-
tructions. The USF group published their experience with
ntibiotic-impregnated beads with a very dogmatic ap-
roach to VSSI.20 This included intraoperative Gram stain
ith subsequent determination of antibiotic bead type (ie,
ram-positive vs -negative coverage), with subsequent se-
ial washouts and cultures in attempts to achieve “wound
terilization” before the definitive procedure. By serial
ashouts and beads implants, wound sterilization was
chieved in 87%. This required a mean number of bead
hanges in their cohort of 2.5.
As demonstrated in this study, most VSSIs are caused
y gram-positive bacteria, especially MRSA, which has
merged as the most prevalent pathogen (33% of cases).
he major risk factors for developing VSSI are nasal car-
iage of methicillin-sensitive or methicillin-resistant S au-
eus strains, recent hospitalization, failed arterial recon-
truction, and a groin incision.6
At our institution, intraoperative Gram stain can take a
onsiderable amount of time or is unavailable; therefore,
mpiric placement of vancomycin beads was instituted at
he initial operation, with or without a gram-negative cul-
tions
strategy Final procedure for recurrent infection
C Repeat irrigation and debridement
C Repeat irrigation and debridement
Cryoartery in situ
Extra-anatomic reconstruction
Repeat irrigation and debridement
GP sinus tract 2 years later
tery Axillopopliteal bypass with graft failure and limb loss
; GP, graft preservation;MRSA,methicillin-resistant Staphylococcus aureus;
closure.infec
ment
F/VA
F/VA
ein
ryoar
arteryure, in cases where wound culture results were available
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June 20121710 Stone et albefore the washout. Depending on the clinical appearance
of the surgical site, the need for repeat operative washouts
was assessed by the attending vascular surgeons’ clinical
judgment rather than by culture-driven wound steriliza-
tion. Therefore, the mean number of washouts with bead
placement was less than that of the USF groups, with only
1.4 mean bead changes, with 71.4% receiving only one set
of antibiotic beads.
With a less rigorous approach to wound sterilization
compared with the USF group, our risk of recurrent infec-
tion was higher at 19% vs 11%.6 However, our results are
comparable with other series that have attempted graft
preservation or partial graft excision5,6,21-23 (Table V). Of
the seven sites that developed recurrent infections, six were
polymicrobial. The seventh patient underwent three bead
exchanges until cultures were negative, and then presented
4months later with bleeding from a sinus tract. Partial graft
excision and in situ replacement was performed with cryo-
arterial replacement of an aortobifemoral limb, and the
patient has been without signs of recurrent infection for 2
years.
Our perioperative mortality rate was also similar, with
none of the 34 USF patients or our 40 patients dying 30
days of their index procedure. The disparity between our
results is the risk of late limb loss and subsequent graft
occlusion. Late graft occlusion occurred in eight patients
and eventual limb loss in six. Why our limb loss was
significantly higher during a similar mean follow-up of 2
years in both series is difficult to extrapolate.
This study has several limitations, as seen in many
retrospective articles. Our group, however, attempted to
eliminate selection bias by treating all infected VSSIs in a
similar fashion. Yet, it is difficult to understand how much
the antibiotic beads contribute to the success or failure of
our attempts or how much of the following contributed to
the results in our series: the intravenous antibiotics, the
dilutional effect of pulsatile lavage and peroxide/povidone-
iodine irrigation during the initial washout, the rotational
muscle flap. In addition, the effect of the intravenous and
antibiotic beads cannot be underscored in the results of
Table V. Series reporting management of extracavitary
vascular surgical site infectionsa
First author
Limbs
(N)
30-day
mortality
(%)
Recurrent
infection
(%)
Limb
loss
(%)
Current 42 0 19 19
Stone6 36 0 11 0
Dosluoglu21 26 0 17b 4
Perler22 19 6 16 NA
Armstrong12 89 2 7 0
Calligaro23 33 11 13 13
Calligaro5 141 14 27 13
NA, Not applicable.
aEarly and late limb loss.
bIn Szilagyi III infections.treatment of this complicated problem. Vancomycin,hich was the MRSA agent of choice, has limited biofilm
enetration, and although considered a bacteriocidal agent,
as had a decreasing sensitivity to MRSA at our institution.
Extra-anatomic bypass, such as obturator bypass, is
learly not the panacea. Three cases performed at our
nstitution during this interval, one of which was in this
eries and two other patients who presented with hemor-
hage and are not included, all had limb loss24months of
heir procedure. Only prospective trials would answer this
uestion or larger series, which we hope not to achieve.
ONCLUSIONS
Antibiotic-loaded PMMA beads may serve as an ad-
unct in the management of VSSIs and may also expand
reatment options for graft preservation or in situ recon-
truction, with expected recurrent infection rate approach-
ng 20%. Further experience with this adjunct may help
lucidate its role in the management of this complicated
roblem, including the need for bead exchanges, until
erigraft cultures are free of microbes.
UTHOR CONTRIBUTIONS
onception and design: PS, AM, SH
nalysis and interpretation: PS, AM, JC, AA, ST, DD, AP,
SH
ata collection: PS, DD, AP, ST
riting the article: PS, AM, AA, JC, DD, ST
ritical revision of the article: PS, AA,
inal approval of the article: PS, AM, JC, AA, ST, DD, AP,
SH
tatistical analysis: ST
btained funding: Not applicable
verall responsibility: PS
EFERENCES
1. Herscu G, Wilson SE. Prosthetic infection: lessons from treatment of
the infected vascular graft. Surg Clin North Am 2009;89:391-401, viii.
2. van Assen S, Houwerzijl EJ, van den Dungen JJ, Koopmans KP.
Vascular graft infection due to chronic Q fever diagnosed with fusion
positron emission tomography/computed tomography. J Vasc Surg
2007;46:372.
3. Atahan E, Gul M, Ergun Y, Eroglu E. Vascular graft infection by
Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomy-
cin prophylaxis protocols in a rat model. Eur J Vasc Endovasc Surg
2007;34:182-7.
4. Seeger JM. Management of patients with prosthetic vascular graft
infection. Am Surg 2000;66:166-77.
5. Calligaro KD, Veith FJ, Schwartz ML, Dougherty MJ, DeLaurentis
DA. Differences in early versus late extracavitary arterial graft infections.
J Vasc Surg 1995;22:680-5; discussion: 685-8.
6. Stone PA, Armstrong PA, Bandyk DF, Brumberg RS, Flaherty SK, Back
MR, et al. Use of antibiotic-loaded polymethylmethacrylate beads for
the treatment of extracavitary prosthetic vascular graft infections. J Vasc
Surg 2006;44:757-61.
7. Henke PK, Bergamini TM, Rose SM, Richardson JD. Current options
in prosthetic vascular graft infection. Am Surg 1998;64:39-45; discus-
sion: 45-6.
8. Knosalla C, Goëau-Brissonnière O, Leflon V, Bruneval P, Eugène M,
Pechère JC, et al. Treatment of vascular graft infection by in situ
replacement with cryopreserved aortic allografts: an experimental study.
J Vasc Surg 1998;27:689-98.
11
2
2
2
2
JOURNAL OF VASCULAR SURGERY
Volume 55, Number 6 Stone et al 17119. Gassel HJ, Klein I, Steger U, Kellersmann R, Hamelmann W, Franke S,
et al. Surgical management of prosthetic vascular graft infection: com-
parative retrospective analysis of 30 consecutive cases. Vasa 2002;31:
48-55.
10. Bunt TJ, Haynes JL. Synthetic vascular graft infection. The continuing
headache. Am Surg 1984;50:43-8.
11. Saleem BR, Meerwaldt R, Tielliu IF, Verhoeven EL, van den Dungen
JJ, Zeebregts CJ. Conservative treatment of vascular prosthetic graft
infection is associated with high mortality. Am J Surg 2010;200:47-52.
12. Armstrong PA, Back MR, Bandyk DF, Johnson BL, Shames ML.
Selective application of sartorius muscle flaps and aggressive staged
surgical debridement can influence long-term outcomes of complex
prosthetic graft infections. J Vasc Surg 2007;46:71-8.
13. Sugawara Y, Sueda T, Orihashi K, Okada K, Wada H, Imai K, et al.
Retro-sartorius bypass in the treatment of graft infection after peripheral
vascular surgery. J Vasc Surg 2003;37:892-4.
14. Sautner T, Niederle B, Herbst F, Kretschmer G, Polterauer P, Rendl
KH, et al. The value of obturator canal bypass. A review. Arch Surg
1994;129:718-22.
15. Shue WB, Worosilo SC, Donetz AP, Trooskin SZ, Harvey RA, Greco
RS. Prevention of vascular prosthetic infection with an antibiotic-
bonded Dacron graft. J Vasc Surg 1988;8:600-5.
16. Torsello G, Sandmann W. Use of antibiotic-bonded grafts in vascular
graft infection. Eur J Vasc Endovasc Surg 1997;14(Suppl A):84-7.17. Javerliat I, Goëau-Brissonnière O, Sivadon-Tardy V, Coggia M, Gail-
lard JL. Prevention of Staphylococcus aureus graft infection by a new Sgelatin-sealed vascular graft prebonded with antibiotics. J Vasc Surg
2007;46:1026-31.
8. Sacar M, Goksin I, Baltalarli A, Turgut H, Sacar S, Onem G, et al. The
prophylactic efficacy of rifampicin-soaked graft in combination with
systemic vancomycin in the prevention of prosthetic vascular graft
infection: an experimental study. J Surg Res 2005;129:329-34.
9. Coggia M, Goëau-Brissonnière O, Leflon V, Nicolas MH, Pechère JC.
Experimental treatment of vascular graft infection due to Staphylococ-
cus epidermidis by in situ replacement with a rifampin-bonded polyester
graft. Ann Vasc Surg 2001;15:421-9.
0. Bandyk DF. Vascular surgical site infection: risk factors and preventive
measures. Semin Vasc Surg 2008;21:119-23.
1. Dosluoglu HH, Loghmanee C, Lall P, Cherr GS, Harris LM, Dryjski
ML. Management of early (30 day) vascular groin infections using
vacuum-assisted closure alone without muscle flap coverage in a con-
secutive patient series. J Vasc Surg 2010;51:1160-6.
2. Perler BA, Vander Kolk CA, Manson PM, Williams GM. Rotational
muscle flaps to treat localized prosthetic graft infection: long-term
follow-up. J Vasc Surg 1993;18:358-65.
3. Calligaro KD, Veith FJ, Gupta SK, Ascer E, Dietzek AM, Franco CD, et
al. A modified method for management of prosthetic graft infections
involving an anastomosis to the common femoral artery. J Vasc Surg
1990;11:485-92.ubmitted Sep 15, 2011; accepted Dec 18, 2011.
